Shu Takagai
Research Subjects
Shu Takagai has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Eiji Kasai
Department of Psychiatry and Neurology Hamamatsu University School of Medicine Hamamatsu, Japan
1 shared publicationHiroaki Itoh
Department of Obstetrics & Gynaecology
1 shared publication- Katsuaki Suzuki
Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan
1 shared publication Kazutaka Nakasato
Department of Psychiatry and Neurology Hamamatsu University School of Medicine Hamamatsu, Japan
1 shared publication- Kenji J. Tsuchiya
Research Center for Child Mental Development Hamamatsu University School of Medicine Hamamatsu Japan
1 shared publication Naohiro Kanayama
Department of Obstetrics & Gynaecology
1 shared publication
Latest Publications
- Open Access
- 31 October 2015
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 45 (2) , 333-342
Cohort Profile: Hamamatsu Birth Cohort for Mothers and Children (HBC Study)
The Hamamatsu Birth Cohort for Mothers and Children (HBC Study) was designed to elucidate the early developmental trajectories of children living in the community in Japan. Derailed developmental patterns are expected among children who are later diagnosed with neurodevelopmental abnormalities. Among such conditions, autism spectrum disorder (ASD) has attracted considerable attention worldwide. Although there are currently no established treatments to reduce ASD symptoms, 1,2 there is accumulating evidence that behavioural interventions, if provided early in life, can improve outcomes in many domains, such as cognitive, social, communication and even academic skills. 3–5 Therefore, early detection and diagnosis of ASD has been a major focus of public health strategy, and a range of procedures that may address early and correct detection of the disorder have been proposed, including screening tools and clinical guidelines. 6–9 However, even though ASD is generally associated with lifelong impairment, recent reports have suggested that symptoms of ASD may resolve among children who have received a diagnosis of ASD early in life. 10,11 The inconsistency of these findings has led to parental concerns regarding the accuracy of early ASD diagnoses. 12
- 31 October 2015
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 45 (2) , 333-342
Open AccessCohort Profile: Hamamatsu Birth Cohort for Mothers and Children (HBC Study)
The Hamamatsu Birth Cohort for Mothers and Children (HBC Study) was designed to elucidate the early developmental trajectories of children living in the community in Japan. Derailed developmental patterns are expected among children who are later diagnosed with neurodevelopmental abnormalities. Among such conditions, autism spectrum disorder (ASD) has attracted considerable attention worldwide. Although there are currently no established treatments to reduce ASD symptoms, 1,2 there is accumulating evidence that behavioural interventions, if provided early in life, can improve outcomes in many domains, such as cognitive, social, communication and even academic skills. 3–5 Therefore, early detection and diagnosis of ASD has been a major focus of public health strategy, and a range of procedures that may address early and correct detection of the disorder have been proposed, including screening tools and clinical guidelines. 6–9 However, even though ASD is generally associated with lifelong impairment, recent reports have suggested that symptoms of ASD may resolve among children who have received a diagnosis of ASD early in life. 10,11 The inconsistency of these findings has led to parental concerns regarding the accuracy of early ASD diagnoses. 12
- 1 August 2012
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 32 (4) , 563-564
Improvement in Intractable Tardive Dystonia in Bipolar Disorder After Aripiprazole Treatment
- 1 August 2012
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 32 (4) , 563-564
Improvement in Intractable Tardive Dystonia in Bipolar Disorder After Aripiprazole Treatment